Session Details

S043 Psoriasis: Modern Therapeutic Approaches

Sun, Mar 21, 1:00 PM - 4:00 PM
3 CME Available Symposium ARS

DESCRIPTION

Psoriasis is a systemic immuno-metabolic disease. This symposium emphasizes new advances in genomics which may inform treatment selection and, in complex cases, diagnosis, advances in biologics and oral small molecules with a special emphasis on patients with recalcitrant disease, and novel approaches to treating the cardiometabolic aspects of psoriatic disease.

LEARNING OBJECTIVES

1.

Examine modern genomic approaches to inform diagnosis and treatment of psoriasis

2.

Develop advanced knowledge of biologics and small molecules to manage complex cases of psoriasis

3.

Treat psoriasis as a systemic cardiometabolic disease

SCHEDULE

1:00 PM

Use of genomics to inform psoriasis treatment selection

1:20 PM

Is it eczema, is it psoriasis?

Matthew Vesely, MD, PhD, FAAD

1:40 PM

Management of biologic treatment failure

Bruce Elliot Strober, MD, PhD, FAAD

2:00 PM

Debate Intro

Joel M. Gelfand, MD, MSCE, FAAD

2:03 PM

Dermatologists should prescribe GLP1 agonists for psoriasis patients with obesity

Jennifer Soung, MD, FAAD

2:13 PM

Dermatologists should not prescribe GLP1 agonists for psoriasis patients with obesity

Eingun James Song, MD, FAAD

2:23 PM

Dr Jennifer Soung rebuttal

Jennifer Soung, MD, FAAD

2:25 PM

Dr James Song rebuttal

Eingun James Song, MD, FAAD

2:27 PM

Final vote

Joel M. Gelfand, MD, MSCE, FAAD

2:30 PM

Dose escalation and deescalation of biologics for psoriasis

Andrew Blauvelt, MD, FAAD

2:50 PM

Pustular Psoriasis: Perils and Promise

Kristina Patrice Callis-Duffin, MD, FAAD

3:10 PM

Novel oral treatment options for psoriasis and psoriatic arthritis

Alice B. Gottlieb, MD, PhD, FAAD

3:30 PM

Cardiovascular risk in psoriasis: What is new for you to do

Joel M. Gelfand, MD, MSCE, FAAD

3:50 PM

Final questions (time permitting)

DIRECTOR

Joel M. Gelfand, MD, MSCE, FAAD

Joel M. Gelfand, MD, MSCE, FAAD

University of Pennysylvania Perelman School of Medicine

SPEAKERS

Andrew Blauvelt, MD, FAAD

Andrew Blauvelt, MD, FAAD

Kristina Patrice Callis-Duffin, MD, FAAD

Kristina Patrice Callis-Duffin, MD, FAAD

Alice B. Gottlieb, MD, PhD, FAAD

Alice B. Gottlieb, MD, PhD, FAAD

Ut Southwestern Medical Center, Dallas, TX

Eingun James Song, MD, FAAD

Eingun James Song, MD, FAAD

Frontier Dermatology

Jennifer Soung, MD, FAAD

Jennifer Soung, MD, FAAD

Harbor University of California Los Angeles

Bruce Elliot Strober, MD, PhD, FAAD

Bruce Elliot Strober, MD, PhD, FAAD

Matthew Vesely, MD, PhD, FAAD

Matthew Vesely, MD, PhD, FAAD

Yale University

DISCLOSURES

Andrew Blauvelt, MD, FAAD

AbbVie – Consultant(Honoraria); Almirall – Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); AnaptysBio – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); Janssen-Ortho Inc. – Consultant(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Consultant(Honoraria); Regeneron – Consultant(Honoraria); Sanofi – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);

Kristina Patrice Callis-Duffin, MD, FAAD

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria), Stockholder Public Company(No Compensation Received); Alumis – Investigator(Grants/Research Funding); Amgen – Advisory Board(Honoraria), Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Celgene Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding); FIDE – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Stockholder Public Company(No Compensation Received);

Joel M. Gelfand, MD, MSCE, FAAD

AbbVie – Consultant(Fees); Alumis – Consultant (1099 relationship)(Fees); Alyson Oliver Partner & Attorney – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Arnold & Porter – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Bristol Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); FIDE – Consultant(Fees); Healio – Other(Fees); Inmagene Biopharmaceuticals – Data Safety Monitoring Board(Fees); International Psoriasis Council – Board of Directors(No Compensation Received); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Consultant(Fees); Maui Derm – Speaker/Faculty Education(Fees); Medical Dermatology Society – Board of Directors(No Compensation Received); Moonlake – Data Safety Monitoring Board(Fees); National Psoriasis Foundation – Investigator(Grants/Research Funding); Neuroderm LTD – Other(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant (1099 relationship)(Fees);

Alice B. Gottlieb, MD, PhD, FAAD

AstraZeneca – Consultant (1099 relationship)(Honoraria); Biogen – Consultant (1099 relationship)(Honoraria); BMS – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria); Galderma – Consultant (1099 relationship)(Honoraria); janssen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant(Honoraria); Novartis – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); sanofi-aventis – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); ucb – Advisory Board(Honoraria);

Eingun James Song, MD, FAAD

AbbVie – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Amgen – Investigator(Grants/Research Funding), Speaker(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bambusa Therapeutics Inc – Consultant (1099 relationship)(Fees); BMS – Investigator(Grants/Research Funding); Eli Lilly – Speaker/Faculty Education(Honoraria); Galderma – Speaker(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding), Speaker(Honoraria); Janssen – Investigator(Grants/Research Funding); Janssen Biotech – Speaker(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Organon – Speaker/Faculty Education(Honoraria); Oruka Therapeutics – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria); Spyre Therapeutics – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); UCB – Speaker(Honoraria);

Jennifer Soung, MD, FAAD

AbbVie – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Alumis – Investigator(Grants/Research Funding); Amgen – Speaker(Honoraria); Arcutis, Inc. – Consultant(Honoraria); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Boehringer Ingelheim – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Dermavant Sciences – Consultant(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Evelo Biosciences, Inc. – Advisory Board(Honoraria); Galderma USA – Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Incyte Corporation – Speaker/Faculty Education(Honoraria); Janssen Biotech – Investigator(Grants/Research Funding), Speaker(Honoraria); Kobio Labs – Investigator(Fees); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria), Investigator(Grants/Research Funding); LEO Pharma, US – Speaker/Faculty Education(Honoraria); National Psoriasis Foundation – Speaker/Faculty Education(Honoraria); Novartis – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Ortho Dermatologics – Consultant(Honoraria), Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Regeneron – Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding);

Bruce Elliot Strober, MD, PhD, FAAD

AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Johnson and Johnson – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Speaker(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria);

Matthew Vesely, MD, PhD, FAAD

Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Almirall – Consultant (1099 relationship)(Fees); First Tracks Biotherapeutics – Advisory Board(Fees); Priovant Therapeutics – Consultant (1099 relationship)(Fees); Regeneron – Employee(Salary);